这是演示店铺,请务下单付款,避免造成你的财物损失。

为了获得访问"阿拉丁铁蛋"实时聊天框的流畅支持体验,建议您使用Chrome浏览器或选择360浏览器极速模式(如何切换极速模式?),感谢您选择我们!

Infliximab (anti-TNF-alpha)

功能和特点
  • 规格或纯度: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
  • 应用: ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR)
  • 反应种属: Cynomolgus,Human
  • 亚型: Human IgG1
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
I412009-1mg (试用装)
申请此免费试用装(?)
作为尊贵的客户,您每年可免费申请一次试用装产品,尽享探索与享受!
1mg 现货 Stock Image
I412009-5mg
5mg 现货 Stock Image
I412009-10mg
10mg 期货 Stock Image

基本信息

产品名称 Infliximab (anti-TNF-alpha)
别名 Infliximab; Remicade; Remsima; Inflectra; Avakine; CT-P13; 英夫利昔单抗; APC1 antibody; APC1 protein antibody; Cachectin antibody; DIF antibody; Differentiation inducing factor antibody; Macrophage cytotoxic factor antibody; Tnf antibody; TNF superfamily member
英文别名 Infliximab; Remicade; Remsima; Inflectra; Avakine; CT-P13; APC1 antibody; APC1 protein antibody; Cachectin antibody; DIF antibody; Differentiation inducing factor antibody; Macrophage cytotoxic factor antibody; Tnf antibody; TNF superfamily member 2 antib
规格或纯度 Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
特异性 TNFSF2/TNFa
应用 ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR)
反应种属 Cynomolgus,Human

产品属性

抗体类型 Primary antibody
Format Whole IgG
亚型 Human IgG1
轻链亚型 Kappa
SDS-PAGE 27.6 kDa (Light Chain) & 52.7 kDa (Heavy Chain), under reducing conditions; 186.7 kDa, under non-reducing conditions.
纯化方法 Protein A purified
来源 CHO supernatant
物理外观 Liquid
储存缓冲液 Supplied as a 0.22 μm filtered solution in 100mM Pro-AC, 20mM Arg, pH 5.0
防腐剂 No
浓度 Lot by Lot
储存温度 -80℃储存,避免反复冻融
运输条件 超低温冰袋运输
稳定性与储存 Store at -80℃ for 18 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
CAS编号和信息 170277-31-3

质检证书(COA)

质检报告(COA)

输入批号以搜索COA:

图片

Infliximab (anti-TNF-alpha) (I412009) - ELISA
Immobilized Recombinant Human TNF-alpha Protein (rp156007) at 0.5 μg/mL can bind Infliximab (anti-TNF-alpha) (I412009) with the EC₅₀ of 31.52 ng/mL.

Infliximab (anti-TNF-alpha) (I412009) - SEC
The purity of Infliximab (anti-TNF-alpha) (I412009) is more than 95% verified by HPLC.

产品问答

产品问答

登录提交问题 Hover me 请先登录再提交问题
您好,Infliximab (anti-TNF-alpha),货号I412009-1mg,网站页说到,储存缓冲液为Supplied as a 0.22 μm filtered solution in 100mM Pro-AC, 20mM Arg, pH 5.0。请问100mM Pro-AC是什么物质,Pro-AC是protein A和protein C吗?
问题由 韦晓云 于 2023年10月26日 上午11:09 创建

您好,该产品的储存缓冲液Pro-AC是指脯氨酸醋酸缓冲液。

参考文献

1. Rutgeerts P, D'Haens G, Targan S, Vasiliauskas E, Hanauer SB, Present DH, Mayer L, Van Hogezand RA, Braakman T, DeWoody KL et al..  (1999)  Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease..  Gastroenterology,  117  (4):  (761-9).  [PMID:10500056]
2. Blair HA, Deeks ED.  (2016)  Infliximab Biosimilar (CT-P13; Infliximab-dyyb): A Review in Autoimmune Inflammatory Diseases..  BioDrugs,  30  (5):  (469-480).  [PMID:27650650]
3. Yoo DH, Prodanovic N, Jaworski J, Miranda P, Ramiterre E, Lanzon A, Baranauskaite A, Wiland P, Abud-Mendoza C, Oparanov B et al..  (2017)  Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study..  Ann Rheum Dis,  76  (2):  (355-363).  [PMID:27130908]
4. Derzi M, Johnson TR, Shoieb AM, Conlon HD, Sharpe P, Saati A, Koob S, Bolt MW, Lorello LG, McNally J et al..  (2016)  Nonclinical Evaluation of PF-06438179: A Potential Biosimilar to Remicade(®) (Infliximab)..  Adv Ther,  33  (11):  (1964-1982).  [PMID:27585978]
5. van Dullemen HM, van Deventer SJ, Hommes DW, Bijl HA, Jansen J, Tytgat GN, Woody J.  (1995)  Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)..  Gastroenterology,  109  (1):  (129-35).  [PMID:7797011]
6. A-González N, Castrillo A.  (2011)  Liver X receptors as regulators of macrophage inflammatory and metabolic pathways..  Biochim Biophys Acta,  1812  (8):  (982-94).  [PMID:21193033]

计算器